| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 20,891 | 20,641 | 21,249 | 21,453 | | Cost of Revenue | 3,338 | 3,562 | 3,939 | 4,664 | | | Gross Profit | 17,553 | 17,079 | 17,310 | 16,789 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,512 | 10,512 | 9,679 | 9,667 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 1,513 | 2,187 | 2,138 | 2,364 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 5,528 | 4,380 | 5,493 | 4,758 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 5,528 | 4,380 | 5,493 | 4,758 | | Interest Expense | 1,561 | 1,691 | 1,905 | 2,191 | | Income Before Tax | 3,967 | 2,689 | 3,588 | 2,567 | | Income Tax Expense | 1,009 | 653 | 631 | 183 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,958 | 2,036 | 2,957 | 2,384 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,958 | 2,036 | 2,957 | 2,384 | | Preferred Stock And Other Adjustments |
-
| (726) | (358) | (47) | | | Net Income Applicable To Common Shares | $2,958 | $1,310 | $2,599 | $2,337 |
|
0.43% Nasdaq 
Income Statement
